This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

NICE guidance - erectile dysfunction in type 2 diabetes

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • NICE have issued guidance concerning the management of erectile dysfunction in patients with type 2 diabetes:
    • review the issue of erectile dysfunction with men annually
    • provide assessment and education for men with erectile dysfunction to address contributory factors and treatment options
    • pharmacological management
      • offer a phosphodiesterase-5 inhibitor (choosing the drug with the lowest acquisition cost), in the absence of contraindications, if erectile dysfunction is a problem
      • if phosphodiesterase-5 inhibitors have been unsuccessful
        • following discussion, refer to a service offering other medical, surgical, or psychological management of erectile dysfunction

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page